Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Viracyte now a Elevate Bio portfolio company. Renamed Allovir. Raises 120 million in Series B.
https://www.fiercebiotech.com/biotech/biotech-builder-elevatebio-reveals-its-first-portfolio-company-allovir
I just bought some more this am. A little surprising how easy it was to fill. But 5/14 is right around the corner.
Great presentation definitely worth a listen. GAAP profit strongly alluded to for q1 as well as revised upward guidance.
https://www.globenewswire.com/Tracker?data=9DfTUXxjENEB7MS-K0279cEv8ItGn02UeYvANuSkY2Sy6tiJAArLybGRyn3ciWuIBqAhmPMrjAzFPbL2w7SwUNqTPXqtQHT41EQrwELQU9A=
No ASCO this May due to submission guideline rules. Hopefully third quarter
https://www.sec.gov/Archives/edgar/data/1094038/000114420419019976/tv519053_8k.htm
And the shorts ??
Here’s the SA article
Marker Therapeutics Exits ASH An Optimist. Should That Be Enough For You? $MRKR https://seekingalpha.com/article/4227821
It’s on the Marker website under News/Media where there is an event calendar. Click on yesterday and Piper presentation will come up
Or
https://markertherapeutics.com/events/.
Inpixon has gone from 10+ to $3 in the last month.
Given that the S3 “assumes” all shares will be sold, Will there be an updated listing at some point of share ownership?
If it’s true seems a little disappointing that Piper initiates Neutral with a $10 PT
$3 was wi$hful thinking Get it $$$
Twocan is a play on toucan. Second marriage thing.......
On StockTwits. The report was an 81% vote by proxy. He said meeting went well. Posted agenda. All items from the proxy nothing new.
Waiting for $3. I mean S3.
From the proxy:
TapImmune’s board believes, based in part on the judgment, advice and analysis of TapImmune’s senior management with respect to the potential strategic, financial and operational benefits of the merger (which judgment, advice and analysis was informed in part on the business, technical, financial, accounting and legal due diligence investigation performed with respect to Marker), that Marker’s proprietary MultiTAA T cell platform has a potentially compelling therapeutic product profile as compared to competitive cell therapy approaches, and has the potential to significantly disrupt the current offerings of gene-modified T cell therapies, including CAR-T and TCR approaches. TapImmune believes that Marker’s technology has the potential to lead to the development and commercialization of immunotherapies for the treatment of hematological malignancies and solid tumors.
What??? I vividly see Sharma in the TPIV equation....but the Brahmin equation....?......"Here's to dear old Boston, The home of the bean and the cod, Where Lowells speak only to Cabots, And Cabots speak only to God.
Ooof....I Guess I was wrong about the last shake of the tree. Hopefully....this.....is the last shake. Ouch!!
Remaining Long (very) and strong
Bull any thoughts??
Final little shake before positive call ????????
I agree, probably won’t see a milestone payment by 8/2 But still a great company Long over due to report success with the Vorteq
https://seekingalpha.com/article/4189349.
WidePoint Awarded More than $11.4 Million in Government Contractshttps://finance.yahoo.com/news/widepoint-awarded-more-11-4-100000765.html
They’ve just mined over 7 million in Ethereum and about to double their capacity. .74 looks like a steal. And that’s using $450 per ETH....
Phantom..... could this news be of any concern to us?? Or may have been the cause of yesterday’s drop??
https://www.biospace.com/article/fda-places-clinical-hold-on-ziopharma-s-sleeping-beauty-car-t-therapy/
Let them. We know the real truth ????
Marker is private but needs access to capital markets hence merger.
Deal is supposed to be a 50/50 merger of equals with hoeng remaining prez
Baylor U is instrumental.
Not as symbiotic initially as you would imagine Full resources be thrown behind marker tech which appears too good to be true.
I doubled down after merger announcement having been in since 2010 and survived the reverse splits
Unless I’m missing something, this could be gargantuan
They said raise should coincide with merger ...late August hopefully.
I have the same price target .....but without the decimal point in 2020
So is there no symbiotic strategy to TPIVs technology??
I owned TPIV before the Marker merger announcement. But I’m wondering why Marker, who appears to really be on to something and has a 8x valuation to TPIV, would want to merge with our little company? Phantom?? Are the technologies that symbiotic?
I agree. Hopefully .50 will be a 52 week low a year from now :)
Hopefully WYY choosing the first day of the week to report is a foreshadow of good news
Jernigan Capital: Is The Thrill Of Victory Worth The Agony Of Defeat? $JCAPhttp://www.seekingalpha.com/article/4164033
Hopefully his ERII call will put him back over 50%. :)
The answer will be evident in the next few weeks.
Price target of $20. Xmas present expected from ERII. Recent price actions appears to support his thesis
http://www.analystratings.com/articles/b-riley-fbr-sticks-to-their-buy-rating-for-energy-recovery/
Video of HIVES. Mining operations in Iceland
http://www.snappytv.com/tc/6133997/4070374.
Wrong link sorry
A Beaten-Down Small-Cap With No Debt, A Growing Business, And 270% Upside $WYY http://www.seekingalpha.com/article/4120457
Nice Summary of WYY and very illustrative explanation of the investment opportunity. Still very risky especially given the expiration of some of their large gov contracts. But I agree with the author that if a few things can fall into place this could be an easy double or more in 2018
WidePoint Corporation to Announce Third Quarter 2017 Financial Results on November 14, 2017 $WYY http://www.seekingalpha.com/article/16988835
In the first quarter of fiscal year 2018, U.S. Global Investors, Inc., through its wholly-owned subsidiary, U.S. Global Investors (Canada) Limited (“USCAN”), purchased 10 million shares of HIVE (approximately $2.4 million USD). In addition, USCAN purchased shares of a fund managed by our 65 percent owned subsidiary, Galileo Global Equity Advisors, Inc. The Galileo Partners Fund purchased 7 million shares of HIVE. These shares are restricted and not available for resale until January 2018. U.S. Global Investors has approximately 15.2 million total common stock shares issued and outstanding.
If you like PRELF/HIVE. You'll LOVE GROW. Grow owns 17 million shares of hive. No brainer. Huge discount to NAV Great crypto currency/back end play. Given hive will retain large percentage of mined coins/tokens. Infrastructure now diversified to Sweden in case Iceland volcano acts up. Redundant infrastructure is smart!!!